Fundraising FoxLIfT Biosciences
1 known investors
Find your way into LIfT Biosciences
Sign up to find every way you can get introduced to LIfT Biosciences
- Your email: who you already know at LIfT Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the LIfT Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients. The company is preparing a first-in-human Phase 1 trial in patients with advanced cervical, head, and neck cancers.
Investors · 1
Frequently asked questions
- What does LIfT Biosciences do?
- Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients. The company is preparing a first-in-human Phase 1 trial in patients with advanced cervical, head, and neck cancers.
- Who are LIfT Biosciences's investors?
- LIfT Biosciences's investors include Lifespan Vision Ventures.